Systematic analysis of the IL ‐17 receptor signalosome reveals a robust regulatory feedback loop
Open Access
- 21 July 2020
- journal article
- research article
- Published by European Molecular Biology Organization in The EMBO Journal
- Vol. 39 (17), e104202
- https://doi.org/10.15252/embj.2019104202
Abstract
IL‐17 mediates immune protection from fungi and bacteria, as well as it promotes autoimmune pathologies. However, the regulation of the signal transduction from the IL‐17 receptor (IL‐17R) remained elusive. We developed a novel mass spectrometry‐based approach to identify components of the IL‐17R complex followed by analysis of their roles using reverse genetics. Besides the identification of linear ubiquitin chain assembly complex (LUBAC) as an important signal transducing component of IL‐17R, we established that IL‐17 signaling is regulated by a robust negative feedback loop mediated by TBK1 and IKKε. These kinases terminate IL‐17 signaling by phosphorylating the adaptor ACT1 leading to the release of the essential ubiquitin ligase TRAF6 from the complex. NEMO recruits both kinases to the IL‐17R complex, documenting that NEMO has an unprecedented negative function in IL‐17 signaling, distinct from its role in NF‐κB activation. Our study provides a comprehensive view of the molecular events of the IL‐17 signal transduction and its regulation.Keywords
Funding Information
- Grantová Agentura České Republiky (17‐27355Y, 18‐24070Y)
- H2020 European Research Council (FunDiT)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (IZ11Z0_166538)
- Ostravská Univerzita v Ostravě (IRP03_2018‐2020)
- Ministerstvo Školství, Mládeže a Tělovýchovy (SGS02/LF/2017‐2018, SGS01/LF/2018‐2019)
- European Molecular Biology Organization (4420)
- Univerzita Karlova v Praze (PRIMUS/20/MED/003)
- Wellcome Trust (207769/A/17/Z)
- Univerzita Karlova v Praze (UNCE/MED/016)
This publication has 90 references indexed in Scilit:
- Discovery of the IL-23/IL-17 Signaling Pathway and the Treatment of PsoriasisJournal Of Immunology, 2018
- A systematic review and meta-analysis of the efficacy and safety of the interleukin (IL)-12/23 and IL-17 inhibitors ustekinumab, secukinumab, ixekizumab, brodalumab, guselkumab and tildrakizumab for the treatment of moderate to severe plaque psoriasisJournal of Dermatological Treatment, 2018
- IL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicansPublished by The American Association of Immunologists ,2015
- CIKS/DDX3X Interaction Controls the Stability of the Zc3h12a mRNA Induced by IL-17The Journal of Immunology, 2015
- HuR Is Required for IL-17–Induced Act1-Mediated CXCL1 and CXCL5 mRNA StabilizationThe Journal of Immunology, 2013
- Structural basis of receptor sharing by interleukin 17 cytokinesNature Immunology, 2009
- Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasisThe Journal of Experimental Medicine, 2009
- Are the IKKs and IKK-related kinases TBK1 and IKK-ɛ similarly activated?Trends in Biochemical Sciences, 2008
- Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-κB activationNature, 2006
- Role of the adaptor protein CIKS in the activation of the IKK complexBiochemical and Biophysical Research Communications, 2003